Product Name: Human B7-H3 / CD276 Antibody (MirzotamAb, Research Use)
Catalog Number: NBR-0712
Target Name: B7-H3 / CD276
Trade Name: MirzotamAb
Antibody Drug Description: Mirzotamab clezutoclax (ABBV-155) is a first-in-class antibody drug conjugate comprised of a BCL-XL (B-cell lymphoma - extra long) inhibitor, solubilizing linker, and a monoclonal anti-B7H3 antibody. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CD276
Synonyms: B7-H3
Target Description: May participate in the regulation of T-cell-mediated immune response. May play a protective role in tumor cells by inhibiting natural-killer mediated cell lysis as well as a role of marker for detection of neuroblastoma cells.
Ensembl: ENSG00000103855
Uniprot: Q5ZPR3